Search - tctmd.com

Displaying 901 - 920 of 3080

Sort: Relevancy | Date

News Conference News EuroPCR 2017

Best Antiplatelet Therapy in Real-World PCI? European Registries Fuel the Debate

Caitlin E. Cox

May 22, 2017

Presentation EuroPCR 2017

First Report of a 2.0 mm ZotarolimusEluting Stent for the Treatment of Very Small Coronary Vessels

Presenter: Matthew J. Price

May 19, 2017

News Conference News EuroPCR 2017

Slimmest Stent to Date Looks Promising in Small Study

Shelley Wood

May 19, 2017

Presentation EuroPCR 2017

BIO-RESORT Silent Diabetes

Presenter: Clemens von Birgelen

May 19, 2017

News Conference News EuroPCR 2017

Scaffold Thrombosis ‘Unpredictable’ With Absorb: AIDA Analysis

Michael O'Riordan

May 19, 2017

Presentation EuroPCR 2017

Association between Radial or Femoral Access and Acute Kidney Injury in Patients with Acute Coronary Syndromes Undergoing Invasive Management

Presenter: Bernando Cortese

May 19, 2017

News Industry News

Medtronic RESOLUTE ONYX(TM) 2.0 mm Clinical Study Meets Primary Endpoint in Extra-Small Vessels at One-Year

May 18, 2017

Presentation EuroPCR 2017

Routine Fractional Flow Reserve Measurement after Percutaneous Coronary Intervention The FFR-SEARCH Study

Presenter: Roberto Diletti

May 18, 2017

News Conference News EuroPCR 2017

Transradial PCI in ACS Reduces Risk of Acute Kidney Injury

Michael O'Riordan

May 18, 2017

News Conference News EuroPCR 2017

FFR-SEARCH Explores Potential of Physiologic Assessment After PCI

Caitlin E. Cox

May 18, 2017

Presentation

Interaction Effects of Race/Ethnicity and Sex on Outcomes After PCI

May 18, 2017

News Conference News SCAI 2017

Minority Women Face 50% Increased Risk of Death/MI After PCI Compared With White Men at 1 Year

L.A. McKeown

May 18, 2017

News Conference News EuroPCR 2017

BIO-RESORT: Impaired Glucose Metabolism Linked With Worse Clinical Outcomes After PCI

Michael O'Riordan

May 18, 2017

Podcast

Episode 13: Left Main Revascularization, Bifurcation Stenting, and LAA Closure

May 17, 2017

Presentation EuroPCR 2017

ABSORB Japan Results: 3-year Clinical and Angiographic Results

Presenter: Ken Kozuma

May 17, 2017

Presentation EuroPCR 2017

Randomized Comparison of Everolimus-eluting Bioresorbable Vascular Scaffolds vs. Everolimus-eluting Metallic Stents in Patients with Coronary Artery Disease: 3-year Clinical Outcomes from ABSORB China

Presenter: Runlin Gao

May 17, 2017

Presentation SCAI 2017

Absorb Scaffolds Will Be Used In Most Patients One Day

Presenter: Cindy L Grines

May 17, 2017

No Very Late Scaffold Thrombosis Risk With Absorb BVS in China, Japan

News Conference News EuroPCR 2017

No Very Late Scaffold Thrombosis Risk With Absorb BVS Studies in China, Japan

Michael O'Riordan

May 17, 2017

News Industry News

Micell Technologies Announces MiStent Achieved Primary Endpoint in All-Comers Randomized Clinical Trial Versus Xience

May 16, 2017

News Conference News EuroPCR 2017

DESSOLVE III: MiStent Holds Up Well Against Xience at 12 Months, Hints at Potential Longer-Term Benefit

Michael O'Riordan

May 16, 2017

Advertisement

Best Antiplatelet Therapy in Real-World PCI? European Registries Fuel the Debate

First Report of a 2.0 mm ZotarolimusEluting Stent for the Treatment of Very Small Coronary Vessels

Slimmest Stent to Date Looks Promising in Small Study

BIO-RESORT Silent Diabetes

Scaffold Thrombosis ‘Unpredictable’ With Absorb: AIDA Analysis

Association between Radial or Femoral Access and Acute Kidney Injury in Patients with Acute Coronary Syndromes Undergoing Invasive Management

Medtronic RESOLUTE ONYX(TM) 2.0 mm Clinical Study Meets Primary Endpoint in Extra-Small Vessels at One-Year

Routine Fractional Flow Reserve Measurement after Percutaneous Coronary Intervention The FFR-SEARCH Study

Transradial PCI in ACS Reduces Risk of Acute Kidney Injury

FFR-SEARCH Explores Potential of Physiologic Assessment After PCI

Interaction Effects of Race/Ethnicity and Sex on Outcomes After PCI

Minority Women Face 50% Increased Risk of Death/MI After PCI Compared With White Men at 1 Year

BIO-RESORT: Impaired Glucose Metabolism Linked With Worse Clinical Outcomes After PCI

Episode 13: Left Main Revascularization, Bifurcation Stenting, and LAA Closure

ABSORB Japan Results: 3-year Clinical and Angiographic Results

Randomized Comparison of Everolimus-eluting Bioresorbable Vascular Scaffolds vs. Everolimus-eluting Metallic Stents in Patients with Coronary Artery Disease: 3-year Clinical Outcomes from ABSORB China

Absorb Scaffolds Will Be Used In Most Patients One Day

No Very Late Scaffold Thrombosis Risk With Absorb BVS Studies in China, Japan

Micell Technologies Announces MiStent Achieved Primary Endpoint in All-Comers Randomized Clinical Trial Versus Xience

DESSOLVE III: MiStent Holds Up Well Against Xience at 12 Months, Hints at Potential Longer-Term Benefit

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content